title: A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu.
abstract: BACKGROUND
  Francisella tularensis, the causative agent of tularemia, is one of the most infectious human bacterial pathogens. It is phagocytosed by immune cells, such as monocytes and macrophages. The precise mechanisms that initiate bacterial uptake have not yet been elucidated. Participation of C3, CR3, class A scavenger receptors and mannose receptor in bacterial uptake have been already reported. However, contribution of an additional, as-yet-unidentified receptor for F. tularensis internalization has been suggested.
  
  
  RESULTS
  We show here that cell-surface expressed nucleolin is a receptor for Francisella tularensis Live Vaccine Strain (LVS) and promotes LVS binding and infection of human monocyte-like THP-1 cells. The HB-19 pseudopeptide that binds specifically carboxy-terminal RGG domain of nucleolin inhibits LVS binding and infection of monocyte-like THP-1 cells. In a pull-down assay, elongation factor Tu (EF-Tu), a GTP-binding protein involved in protein translation, usually found in cytoplasm, was recovered among LVS bacterial membrane proteins bound on RGG domain of nucleolin. A specific polyclonal murine antibody was raised against recombinant LVS EF-Tu. By fluorescence and electron microscopy experiments, we found that a fraction of EF-Tu could be detected at the bacterial surface. Anti-EF-Tu antibodies reduced LVS binding to monocyte-like THP-1 cells and impaired infection, even in absence of complement and complement receptors. Interaction between EF-Tu and nucleolin was illustrated by two different pull-down assays using recombinant EF-Tu proteins and either RGG domain of nucleolin or cell solubilized nucleolin.
  
  
  CONCLUSIONS
  Altogether, our results demonstrate that the interaction between surface nucleolin and its bacterial ligand EF-Tu plays an important role in Francisella tularensis adhesion and entry process and may therefore facilitate invasion of host tissues. Since phagosomal escape and intra-cytosolic multiplication of LVS in infected monocytes are very similar to those of human pathogenic F. tularensis ssp tularensis, the mechanism of entry into monocyte-like THP-1 cells, involving interaction between EF-Tu and nucleolin, might be similar in the two subspecies. Thus, the use of either nucleolin-specific pseudopeptide HB-19 or recombinant EF-Tu could provide attractive therapeutic approaches for modulating F. tularensis infection.
authors.affiliation: INSERM U570, Unité de Pathogénie des Infections Systémiques, Université Paris Descartes, Faculté de Médecine Necker Enfants-Malades, 156 rue de Vaugirard, 75730, Paris Cedex 15, France. monique.barel@inserm.fr
authors.forename: Monique
authors.initials: M
authors.lastname: Barel
authors.forename: Ara G
authors.initials: AG
authors.lastname: Hovanessian
authors.forename: Karin
authors.initials: K
authors.lastname: Meibom
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Briand
authors.forename: Marion
authors.initials: M
authors.lastname: Dupuis
authors.forename: Alain
authors.initials: A
authors.lastname: Charbit
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000378:metabolism; D001665:Binding Sites; D002460:Cell Line; D015536:Down-Regulation; D005604:Francisella tularensis / Q000378:metabolism / Q000502:physiology*; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D008024:Ligands; D016177:Macrophage-1 Antigen / Q000235:genetics; D008565:Membrane Proteins / Q000378:metabolism*; D051379:Mice; D009000:Monocytes / Q000378:metabolism* / Q000382:microbiology*; D010444:Peptide Elongation Factor Tu / Q000378:metabolism*; D010455:Peptides / Q000494:pharmacology; D010750:Phosphoproteins / Q000378:metabolism*; D016601:RNA-Binding Proteins / Q000378:metabolism*; D011994:Recombinant Proteins / Q000378:metabolism; D014406:Tularemia / Q000382:microbiology; D000097796:Nucleolin
chemical_list: D000907:Antibodies, Bacterial; D008024:Ligands; D016177:Macrophage-1 Antigen; D008565:Membrane Proteins; D010444:Peptide Elongation Factor Tu; D010455:Peptides; D010750:Phosphoproteins; D016601:RNA-Binding Proteins; D011994:Recombinant Proteins; D000097796:Nucleolin; C121944:HB-19 peptide
references.citation: J Biol Chem. 1998 Aug 21;273(34):21988-97
references.pmid: 9705340
references.citation: Curr Opin Microbiol. 2003 Feb;6(1):66-71
references.pmid: 12615222
references.citation: J Immunol. 2006 Nov 1;177(9):6317-24
references.pmid: 17056562
references.citation: Cell Res. 2006 Feb;16(2):174-81
references.pmid: 16474431
references.citation: J Leukoc Biol. 2006 Sep;80(3):563-71
references.pmid: 16816147
references.citation: Ann N Y Acad Sci. 2007 Jun;1105:160-86
references.pmid: 17435118
references.citation: J Leukoc Biol. 2005 Jun;77(6):893-7
references.pmid: 15758077
references.citation: Infect Immun. 2006 Sep;74(9):5114-25
references.pmid: 16926403
references.citation: Plant Cell. 2004 Dec;16(12):3496-507
references.pmid: 15548740
references.citation: FEMS Microbiol Lett. 2005 Aug 15;249(2):359-66
references.pmid: 16054780
references.citation: Cell Microbiol. 2006 Aug;8(8):1361-70
references.pmid: 16882038
references.citation: Exp Cell Res. 2002 Jun 10;276(2):155-73
references.pmid: 12027446
references.citation: Immunol Rev. 2001 Apr;180:5-15
references.pmid: 11414363
references.citation: Eur J Biochem. 2004 Jan;271(2):303-17
references.pmid: 14717698
references.citation: Appl Environ Microbiol. 2004 Dec;70(12):7511-9
references.pmid: 15574954
references.citation: PLoS Pathog. 2006 Jul;2(7):e71
references.pmid: 16848641
references.citation: J Clin Microbiol. 1993 Jul;31(7):1936-9
references.pmid: 8349780
references.citation: J Biol Chem. 1999 Sep 24;274(39):27875-84
references.pmid: 10488134
references.citation: Mol Microbiol. 2005 Apr;56(2):383-96
references.pmid: 15813732
references.citation: Infect Immun. 2004 Jun;72(6):3204-17
references.pmid: 15155622
references.citation: Infect Immun. 2004 Apr;72(4):2160-9
references.pmid: 15039339
references.citation: J Biol Chem. 2002 Oct 4;277(40):37492-502
references.pmid: 12147681
references.citation: Microbiol Mol Biol Rev. 2007 Dec;71(4):600-19
references.pmid: 18063719
references.citation: BMC Microbiol. 2007 Jan 17;7:1
references.pmid: 17233889
references.citation: Infect Immun. 2005 Sep;73(9):5892-902
references.pmid: 16113308
references.citation: J Bacteriol. 2006 Oct;188(19):6977-85
references.pmid: 16980500
references.citation: Microbiology (Reading). 2002 Oct;148(Pt 10):3161-3171
references.pmid: 12368450
references.citation: Infect Immun. 2005 Dec;73(12):8109-18
references.pmid: 16299305
references.citation: J Biol Chem. 1992 Feb 15;267(5):2955-9
references.pmid: 1737751
references.citation: Microbiology (Reading). 2001 Feb;147(Pt 2):459-471
references.pmid: 11158363
references.citation: FEBS J. 2005 Sep;272(18):4646-59
references.pmid: 16156786
references.citation: Trends Genet. 2003 Aug;19(8):415-7
references.pmid: 12902157
references.citation: Biosci Biotechnol Biochem. 2002 Jan;66(1):1-21
references.pmid: 11866090
references.citation: J Immunol. 2007 Sep 1;179(5):2979-88
references.pmid: 17709513
references.citation: Infect Immun. 1994 Jul;62(7):2779-83
references.pmid: 8005668
references.citation: J Immunol. 2001 Mar 1;166(5):3167-73
references.pmid: 11207269
references.citation: J Immunol Methods. 1989 Aug 15;122(1):105-13
references.pmid: 2760472
references.citation: Infect Immun. 2003 Oct;71(10):5940-50
references.pmid: 14500514
references.citation: Cell. 2006 May 19;125(4):749-60
references.pmid: 16713565
references.citation: Immunol Lett. 2007 Feb 15;108(2):151-9
references.pmid: 17241671
references.citation: Exp Cell Res. 2000 Dec 15;261(2):312-28
references.pmid: 11112338
references.citation: FEBS Lett. 1984 Jan 9;165(2):175-9
references.pmid: 6363121
references.citation: JAMA. 2001 Jun 6;285(21):2763-73
references.pmid: 11386933
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):141-6
references.pmid: 16373510
references.citation: J Mol Biol. 1992 Feb 5;223(3):721-42
references.pmid: 1542116
references.citation: Proteomics. 2005 May;5(8):2090-103
references.pmid: 15892173
references.citation: J Cell Biol. 2003 Nov 24;163(4):871-8
references.pmid: 14638862
references.citation: J Biol Chem. 2002 Jun 7;277(23):20877-86
references.pmid: 11919179
references.citation: FASEB J. 1999 Nov;13(14):1911-22
references.pmid: 10544174
references.citation: J Biol Chem. 2002 Jan 25;277(4):2876-85
references.pmid: 11704679
references.citation: J Biol Chem. 2004 Aug 6;279(32):33751-8
references.pmid: 15173179
references.citation: Neuroscience. 2007 Aug 10;148(1):250-65
references.pmid: 17614212
references.citation: Mol Biol Rep. 1996;23(3-4):191-5
references.pmid: 9112228